Temperature-controlled magnetic nanoparticles hyperthermia inhibits primary tumor growth and metastases dissemination.


Journal

Nanomedicine : nanotechnology, biology, and medicine
ISSN: 1549-9642
Titre abrégé: Nanomedicine
Pays: United States
ID NLM: 101233142

Informations de publication

Date de publication:
04 2020
Historique:
received: 05 08 2019
revised: 30 12 2019
accepted: 03 02 2020
pubmed: 23 2 2020
medline: 26 5 2021
entrez: 22 2 2020
Statut: ppublish

Résumé

Magnetic hyperthermia (MHT) is a promising approach for cancer therapy. However, a systematic MHT characterization as function of temperature on the therapeutic efficiency is barely analyzed. Here, we first perform comparative temperature-dependent analysis of the cobalt ferrite nanoparticles-mediated MHT effectiveness in two murine tumors models - breast (4T1) and colon (CT26) cancer in vitro and in vivo. The overall MHT killing capacity in vitro increased with the temperature and CT26 cells were more sensitive than 4T1 when heated to 43 °C. Well in line with the in vitro data, such heating cured non-metastatic CT26 tumors in vivo, while only inhibiting metastatic 4T1 tumor growth without improving the overall survival. High-temperature MHT (>47 °C) resulted in complete 4T1 primary tumor clearance, 25-40% long-term survival rates, and, importantly, more effective prevention of metastasis comparing to surgical extraction. Thus, the specific MHT temperature must be defined for each tumor individually to ensure a successful antitumor therapy.

Identifiants

pubmed: 32084594
pii: S1549-9634(20)30023-X
doi: 10.1016/j.nano.2020.102171
pii:
doi:

Substances chimiques

Ferric Compounds 0
Magnetite Nanoparticles 0
cobalt ferrite 0
Cobalt 3G0H8C9362

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102171

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Anastasiia S Garanina (AS)

National University of Science and Technology «MISiS», Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia. Electronic address: anastasiacit@gmail.com.

Victor A Naumenko (VA)

National University of Science and Technology «MISiS», Moscow, Russia; National Medical Research Center for Psychiatry and Narcology, Moscow, Russia.

Aleksey A Nikitin (AA)

National University of Science and Technology «MISiS», Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia.

Eirini Myrovali (E)

School of Physics, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Anna Y Petukhova (AY)

National University of Science and Technology «MISiS», Moscow, Russia.

Svetlana V Klimyuk (SV)

National University of Science and Technology «MISiS», Moscow, Russia.

Yulia A Nalench (YA)

National University of Science and Technology «MISiS», Moscow, Russia.

Artem R Ilyasov (AR)

National University of Science and Technology «MISiS», Moscow, Russia.

Stepan S Vodopyanov (SS)

National University of Science and Technology «MISiS», Moscow, Russia.

Alexander S Erofeev (AS)

National University of Science and Technology «MISiS», Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia.

Peter V Gorelkin (PV)

Medical Nanotechnology LLC, Skolkovo Innovation Center, Moscow, Russia.

Makis Angelakeris (M)

School of Physics, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Alexander G Savchenko (AG)

National University of Science and Technology «MISiS», Moscow, Russia.

Ulf Wiedwald (U)

National University of Science and Technology «MISiS», Moscow, Russia; Faculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, Germany.

Alexander G Majouga Dr (AG)

National University of Science and Technology «MISiS», Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia; D. Mendeleev University of Chemical Technology of Russia, Moscow, Russia.

Maxim A Abakumov (MA)

National University of Science and Technology «MISiS», Moscow, Russia; Department of Medical Nanobiotechnology, Russian National Research Medical University, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH